Results 251 to 260 of about 12,522,600 (400)
Community-based pulmonary rehabilitation for post-TB lung disease - a programmatic intervention. [PDF]
Stenberg B+3 more
europepmc +1 more source
Contributions towards the Pathology of Grinders' Disease of the Lungs [PDF]
Jo Waterhouse
openalex +1 more source
STUDIES OF RESPIRATORY PHYSIOLOGY IN CHILDREN. VI. LUNG DIFFUSING CAPACITY, DIFFUSING CAPACITY OF THE PULMONARY MEMBRANE AND PULMONARY CAPILLARY BLOOD VOLUME IN CONGENITAL HEART DISEASE* [PDF]
Giovanni Bucci, Charles D. Cook
openalex +1 more source
ABSTRACT Objective The Apolipoprotein (APOE) ε4 allele is the strongest genetic risk factor for late‐onset Alzheimer's disease (AD); however, many ε4 carriers remain cognitively intact into old age. Leveraging plasma neuron‐derived extracellular vesicles (NDEVs), we sought to identify biomarkers of cognitive resilience and their interplay with APOE ...
Apostolos Manolopoulos+17 more
wiley +1 more source
Cystic and emphysematous lung disease in neurofibromatosis type 1 - A case report. [PDF]
Aziz N+5 more
europepmc +1 more source
Needle Biopsy of the Lung: With Special Reference to Diffuse Lung Disease and the Use of a New Needle [PDF]
William G. Smith
openalex +1 more source
ABSTRACT Objective To estimate the risk of epilepsy associated with stroke in a community‐based cohort, with consideration of stroke type, number, and severity. Methods Data from 15,100 Atherosclerosis Risk in Communities (ARIC) Study participants without stroke at baseline (1987–1989) were analyzed through 12/31/2022.
Jiping Zhou+11 more
wiley +1 more source
Comprehensive analysis of patients with rheumatoid arthritis associated interstitial lung disease. [PDF]
Kim JW, Jung JY, Suh CH, Kim HA.
europepmc +1 more source
Physical training in chronic obstructive lung disease. [PDF]
D. Christie
openalex +1 more source
ABSTRACT Objective To investigate the overall use of prescription medications among individuals with multiple sclerosis compared to the general population, with a focus on treatments beyond disease‐modifying therapies. Methods We conducted a nationwide, registry‐based study in Denmark.
Josefine Windfeld‐Mathiasen+4 more
wiley +1 more source